News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Entertainment

Chrissy Teigen is done airbrushing

Fresh
chrissyteigen

The model doesn't use technology to cover up her blemishes in photos she posts online because she wants young girls to realize that even classic beauties are not perfect.

in Entertainment

Sandra Bullock’s son has no idea his mom is a superstar

sandra

Five-year-old Louis doesn't know his mom is an international movie star.

in Viral Videos

Nonsense karaoke with Chris Pratt and Jimmy Fallon

18-overlay5

The "Guardians of the Galaxy" star takes on the "Tonight Show" host in a battle of who can best butcher a song.

in Entertainment

Hundreds of cinemas refuse to show ‘Avengers’ film

avengers

Theaters in Germany are refusing to show the much-anticipated sequel in a dispute with Disney.